Our Work

Our work

Filter by

Content type
  • Events
  • Expert Spotlight
  • News
  • Publication
  • Research Project
Health Insurance
  • Research Interest
  • Access and Pricing of Prescription Drugs
  • Aging
  • Applied Economics
  • Artificial Intelligence
  • DEI in Healthcare
  • Digital Health
  • Disability
  • Drug Choice
  • Health Analytics
  • Healthcare Marketing
  • Neurodiversity
  • Pharmaceutical Innovation
  • Quality Improvement
  • Social Business Innovation and Investment
  • Behavioral Health and Substance Use Disorder
  • COVID-19 Pandemic or Pandemics
  • Economic Evaluation
  • Economics
  • Entrepreneurship
  • Epidemiology
  • Health Behavior and Behavior Change
  • Health Care Organizations
  • Health Care Policy
  • Health Equity
  • Health Insurance
  • Health Services Research
  • Hospitals
  • Informatics and Information Technology
  • Management
  • Maryland Health Policy
  • Medicare and Medicare Advantage Data Hub
  • National registry data
  • Nurse Practitioners
  • Operations
  • Overuse
  • Patient Safety
  • Physicians
  • Supply Chain
  • Telehealth
Strategic Pillars
  • Health Delivery Performance
  • Health of Populations and Health Equity
  • Innovation: Health Technology and Systems
  • Market Competition and Healthcare Policy
Publication

High Deductible Health Plans and Spending among Families with a Substance Use Disorder

The United States faces an ongoing drug crisis, worsened by the undertreatment of substance use disorders (SUDs). Family enrollment in high deductible health plans (HDHPs) and the resulting increased cost exposure could exacerbate the undertreatment of SUD. This study characterized the distribution of health care spending within families where a member has a SUD and estimated the association between HDHPs and family health care spending.
Publication

Where Do Real-Time Prescription Benefit Tools Fit in the Landscape of High US Prescription Medication Costs? A Narrative Review

While providers are aware of the financial burden of healthcare for patients, there is a lack of actionable price transparency at the point of prescribing. Real-time prescription benefit (RTPB) tools are new electronic clinical decision support tools that retrieve patient- and medication-specific out-of-pocket cost information and display it to clinicians at the point of prescribing.